Skip to content

Cyclin-dependent kinase 7

Concern score

Not assessed — no hazard data yet.

Cyclin-dependent kinase 7 in plain language

What it is

Also known as 39 kda protein kinase · Cak · CAK1 · CDK-7 · Cdk-activating kinase 1 · CDK7

Show all 13 names

CDKN7 · Cell division protein kinase 7 · MO15 · P39 MO15 · Serine/threonine-protein kinase 1 · STK1 · Tfiih basal transcription factor complex kinase subunit

What it does

We don't have a plain-language description for Cyclin-dependent kinase 7 yet.

Is it a concern?
We haven't assessed a concern score for this ingredient yet.

What we know about this ingredient

FDA GSRS classifies this ingredient as ingredient substance protein.

Regulation

No restrictions found. Cyclin-dependent kinase 7 appears in these published regulatory listings.

  • USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as protein.
    • openFDA substance registry classifies this ingredient as protein.Source →

Evidence & sources

No graded research studies for Cyclin-dependent kinase 7 yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.

2 data sources

Where this comes from

  • FDA GSRS UNII

    registry · updated 2026-02-26

    Open →
  • openFDA Substance

    registry · updated 2026-05-24

    Open →
Reference links (3)
Openfda substance

Nemunaitis, J.J., Small, K.A., Kirschmeier, P. et al. A first-in-human, phase 1, dose-escalation study of dinaciclib, a novel cyclin-dependent kinase inhibitor, administered weekly

Openfda substance

cdn.caymanchem.com

Suitability

Context-specific fit derived from published classifications and the current ingredient evidence profile.

Fragrance avoidance

Nothing to weigh for this context yet.

No signal in this context

We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.